GOLDMAN SACHS GROUP INC - CARDIOL THERAPEUTICS INC ownership

CARDIOL THERAPEUTICS INC's ticker is CRTPF and the CUSIP is 14161Y200. A total of 34 filers reported holding CARDIOL THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CARDIOL THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$47,470
+11.6%
23,5000.0%0.00%
Q1 2024$42,535
+114.7%
23,5000.0%0.00%
Q4 2023$19,815
-5.8%
23,5000.0%0.00%
Q3 2023$21,033
+0.6%
23,5000.0%0.00%
Q2 2023$20,915
+74.5%
23,500
-4.5%
0.00%
Q1 2023$11,988
-76.8%
24,600
-75.8%
0.00%
Q4 2022$51,765
-48.2%
101,500
+54.7%
0.00%
Q1 2022$100,000
-57.1%
65,600
-48.0%
0.00%
Q4 2021$233,000
+194.9%
126,100
+560.2%
0.00%
Q3 2021$79,00019,1000.00%
Other shareholders
CARDIOL THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MMCAP International Inc. SPC 2,953,300$2,628,4370.86%
AdvisorShares Investments LLC 1,219,738$1,085,5670.31%
AXS Investments LLC 1,299,076$1,157,1310.31%
Tejara Capital Ltd 497,061$442,3840.22%
MGO ONE SEVEN LLC 100,000$89,0000.01%
Laird Norton Wetherby Trust Company, LLC 61,327$54,5810.01%
Marble Harbor Investment Counsel, LLC 36,900$32,8410.00%
Private Ocean, LLC 15,151$13,4840.00%
Piscataqua Savings Bank 3,000$2,6700.00%
City State Bank 825$10.00%
View complete list of CARDIOL THERAPEUTICS INC shareholders